tradingkey.logo

Quest Diagnostics Inc

DGX
查看詳細走勢圖
184.110USD
+1.550+0.85%
收盤 12/15, 16:00美東報價延遲15分鐘
20.44B總市值
21.37本益比TTM

Quest Diagnostics Inc

184.110
+1.550+0.85%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.85%

5天

+1.26%

1月

-1.52%

6月

+2.16%

今年開始到現在

+22.04%

1年

+18.78%

查看詳細走勢圖

TradingKey Quest Diagnostics Inc股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Quest Diagnostics Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名15/78位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價196.72。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Quest Diagnostics Inc評分

相關信息

行業排名
15 / 78
全市場排名
83 / 4592
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 20 分析師
買入
評級
196.716
目標均價
+8.19%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Quest Diagnostics Inc亮點

亮點風險
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
高分紅
公司屬於高分紅公司,最新股息支付率38.22%
穩定分紅
公司5年內持續分紅,最新股息支付率38.22%
估值高估
公司最新PE估值21.19,處於3年歷史高位
私人資本持倉
明星投資者私人資本持倉,最新持倉8.70K股

Quest Diagnostics Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Quest Diagnostics Inc簡介

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
公司代碼DGX
公司Quest Diagnostics Inc
CEODavis (James E)
網址https://www.questdiagnostics.com/

常見問題

Quest Diagnostics Inc(DGX)的當前股價是多少?

Quest Diagnostics Inc(DGX)的當前股價是 184.110。

Quest Diagnostics Inc 的股票代碼是什麼?

Quest Diagnostics Inc的股票代碼是DGX。

Quest Diagnostics Inc股票的52週最高點是多少?

Quest Diagnostics Inc股票的52週最高點是197.550。

Quest Diagnostics Inc股票的52週最低點是多少?

Quest Diagnostics Inc股票的52週最低點是148.700。

Quest Diagnostics Inc的市值是多少?

Quest Diagnostics Inc的市值是20.44B。

Quest Diagnostics Inc的淨利潤是多少?

Quest Diagnostics Inc的淨利潤為866.00M。

現在Quest Diagnostics Inc(DGX)的股票是買入、持有還是賣出?

根據分析師評級,Quest Diagnostics Inc(DGX)的總體評級為買入,目標價格為196.716。

Quest Diagnostics Inc(DGX)股票的每股收益(EPS TTM)是多少

Quest Diagnostics Inc(DGX)股票的每股收益(EPS TTM)是8.616。
KeyAI